Loading company…
Prothegen is developing medicines designed to regulate cell death and address ferroptosis.
Founded in 2021 and based in California, US, Prothegen is a biotechnology company developing drugs that target ferroptosis, a process by which cells die. The company was co-founded by Davide Zanchi and Scott Dixon. In November 2021, it raised an undisclosed amount in seed funding from SOSV.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in